Standard Surfactants Fund Raise of ₹1.16 Cr

Standard Surfactants Other Announcement

The company submitted its quarterly shareholding pattern as per Regulation 31, detailing the distribution of shareholding among various categories of shareholders.

Standard Surfactants Annual General Meeting

Standard Surfactants Ltd held its 37th Annual General Meeting on 30th September 2026. The meeting covered adoption of financial statements and related party transaction approvals.

Standard Surfactants Annual General Meeting

Standard Surfactants Ltd has submitted its 37th Annual Report for FY 2025-26 and notice for the AGM scheduled on September 30, 2026.

Standard Surfactants Promoter Buying (Off-Market): ₹0.34 Cr

Promoter group members executed inter-se off-market transfers involving 58,000 shares totaling ₹0.34 Crore. The transactions reflect internal realignment within the Garg family.

Value

₹0.34 Cr

Standard Surfactants Q1 FY27 Results: Net Profit ₹6.3 Cr, Up 1160.0% YoY

Standard Surfactants Ltd reported revenue from operations of ₹102.4 Cr (+93.2% YoY) and net profit of ₹6.3 Cr (+1160.0% YoY) for Q1 FY27.

Key figure

Net profit ₹6.3 Cr · +1160.0% YoY

Standard Surfactants Board Meeting Outcome

Standard Surfactants Ltd held a board meeting approving the Q1 FY 2026-27 unaudited financial results. The company also announced the upcoming 37th AGM date and auditor appointment.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr